Related references
Note: Only part of the references are listed.Quantitative Determination of Acetylcholine and Choline in Microdialysis Samples by MALDI-TOF MS
Markus Persike et al.
ANALYTICAL CHEMISTRY (2010)
Amphetamine toxicities Classical and emerging mechanisms
Bryan K. Yamamoto et al.
ADDICTION REVIEWS 2 (2010)
Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists
Amy B. Dounay et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Development of an Efficient Therapeutic Agent for Alzheimer's Disease: Design and Synthesis of Dual Inhibitors of Acetylcholinesterase and Serotonin Transporter
Narihiro Toda et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2010)
Cholinesterase inhibitors and memory
Giancarlo Pepeu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
Xavier Lopez-Gil et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Effect of risperidone on acute methamphetamine-induced hyperthermia in rats
Katsutoshi Shioda et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
The pharmacological properties of antidepressants
Giorgio Racagni et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Review of recent advances in analytical techniques for the determination of neurotransmitters
Maura Perry et al.
ANALYTICA CHIMICA ACTA (2009)
Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes
Simon Sydserff et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Emerging drugs for major depressive disorder
Sidney H. Kennedy et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease
Werner J. Geldenhuys et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
On-line Microdialysis Coupled with Liquid Chromatography for Biomedical Analysis
Guan-Wen Cheng et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2009)
Effects of Rivastigmine and Donepezil on Brain Acetylcholine Levels in Acetylcholinesterase-Deficient Mice
Runa S. Naik et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2009)
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
D. J. Heal et al.
NEUROPHARMACOLOGY (2009)
JNJ-10181457, a selective non-imidazole histamine H3 receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition
Ruggero Galici et al.
NEUROPHARMACOLOGY (2009)
Effects of subthalamic nucleus lesions and stimulation upon glutamate levels in the dopamine-depleted rat striatum
Ruth H. Walker et al.
NEUROREPORT (2009)
Time-Resolved Microdialysis for In Vivo Neurochemical Measurements and Other Applications
Kristin N. Schltz et al.
ANNUAL REVIEW OF ANALYTICAL CHEMISTRY (2008)
Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: The spontaneously hypertensive rat
Li-Li Liu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Selective dopamine D-4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat
Marie L. Woolley et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism
Dinesh V. Raju et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?
Chad E. Beyer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Dual Dopamine/Serotonin Releasers: Potential Treatment Agents for Stimulant Addiction
Richard B. Rothman et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2008)
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1A receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)
Warren D. Hirst et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats
Moises Garcia-Arencibia et al.
NEUROSCIENCE LETTERS (2008)
Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons
Gary A. Gudelsky et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD
D. J. Heal et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Microdialysis of GABA and glutamate: Analysis, interpretation and comparison with microsensors
Miranda van der Zeyden et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain
Michael H. Baumann et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Quantitative liquid chromatography/mass spectrometry for the analysis of microdialysates
Katrien Lanckmans et al.
TALANTA (2008)
Intracerebral Microdialysis technique and its application on brain pharmacokinetic-pharmacodynamic study
Yue-fang Pan et al.
ARCHIVES OF PHARMACAL RESEARCH (2007)
Clozapine and haloperidol differently suppress the MK-801-Increased Glutamatergic and Serotonergic transmission in the medial prefrontal cortex of the rat
Xavier Lopez-Gil et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Phenserine
Jochen Klein
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models
Andrew D. Medhurst et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Methylphenidate and atomoxetine increase histamine release in rat prefrontal cortex
Weldon E. Horner et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity
Joachim Hartmann et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate agonist medications for cocaine dependence: Studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys
S. S. Negus et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
SSR180711, a novel selective α7 nicotinic receptor partial agonist:: (I) binding and functional profile
Bruno Biton et al.
NEUROPSYCHOPHARMACOLOGY (2007)
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models
Warren D. Hirst et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction
Richard B. Rothman et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function
Craig W. Berridge et al.
BIOLOGICAL PSYCHIATRY (2006)
Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats
Dinesh V. Raju et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Multifunctional drugs with different CNS targets for neuropsychiatric disorders
Cornelis J. Van der Schyf et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine
Merce Amargos-Bosch et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex
Mei Huang et al.
BRAIN RESEARCH (2006)
Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat
Chad J. Swanson et al.
NEUROPHARMACOLOGY (2006)
Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: A review
BP Guiard et al.
CURRENT DRUG TARGETS (2006)
ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens
Z Li et al.
PSYCHOPHARMACOLOGY (2005)
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
NH Greig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A-412997 is a selective doparnine D4 receptor agonist in rats
RB Moreland et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration
HK Holmer et al.
SYNAPSE (2005)
Apomorphine-induced alterations in striatal and substantia nigra pars reticulata glutamate following unilateral loss of striatal dopamine
JC Touchon et al.
EXPERIMENTAL NEUROLOGY (2005)
Mechanisms of neurotransmitter release by amphetamines: A review
D Sulzer et al.
PROGRESS IN NEUROBIOLOGY (2005)
Pharmacological properties of ABT-239[4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]:: II.: Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist
GB Fox et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Choline transporters, cholinergic transmission and cognition
M Sarter et al.
NATURE REVIEWS NEUROSCIENCE (2005)
GABA(B) receptors at glutamatergic synapses in the rat striatum
CJ Lacey et al.
NEUROSCIENCE (2005)
l-Dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
HK Holmer et al.
NEUROSCIENCE (2005)
Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: Effects on striatal glutamate and apomorphine-induced contralateral rotations
JC Touchon et al.
SYNAPSE (2004)
Cholinesterase inhibitors: new roles and therapeutic alternatives
E Giacobini
PHARMACOLOGICAL RESEARCH (2004)
Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease
S Robelet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat
SG Nair et al.
BRAIN RESEARCH (2004)
Intralaminar thalamic nuclei lesions: Widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia
JJ Bacci et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release
MG Bankson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease
AG Dervan et al.
EXPERIMENTAL NEUROLOGY (2004)
Changes in acetylcholine extracellular levels during cognitive processes
G Pepeu et al.
LEARNING & MEMORY (2004)
Monoamine transporters and psychostimulant drugs
RB Rothman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
In vivo pharmacological characterization of (±)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand:: microdialysis studies
TS Rao et al.
BRAIN RESEARCH (2003)
Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys
GS Linn et al.
PSYCHOPHARMACOLOGY (2003)
The effect of 6-hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis
L Bianchi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Differential patterns of striatal activation in young children with and without ADHD
S Durston et al.
BIOLOGICAL PSYCHIATRY (2003)
Effects of septal grafts on acetylcholine release from rat hippocampus after 192 IgG-saporin lesion
M Hilgert et al.
NEUROCHEMICAL RESEARCH (2003)
Influence of the 5-HT6 receptor on acetylcholine release in the cortex:: Pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist
C Riemer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function
S Robinson et al.
EXPERIMENTAL NEUROLOGY (2003)
Neurochemical and behavioral differencet between d-methamphetamine and d-amphetamine in rats
JR Shoblock et al.
PSYCHOPHARMACOLOGY (2003)
Intracerebral microdialysis: 30 years as a tool for the neuroscientist
JA Bourne
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2003)
A review of the biological bases of ADHD: What have we learned from imaging studies?
S Durston
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2003)
Acetylcholine modulation of neural systems involved in learning and memory
PE Gold
NEUROBIOLOGY OF LEARNING AND MEMORY (2003)
Improving the oral efficacy of CNS drug candidates:: Discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists
YG Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in Attention Deficit/Hyperactivity Disorder
FP Bymaster et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo:: opposite role for D1 and D2 receptors
M Marti et al.
JOURNAL OF NEUROCHEMISTRY (2002)
SR46349-B, a 5-HT2A/2c receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens
S Bonaccorso et al.
NEUROPSYCHOPHARMACOLOGY (2002)
5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner
JF Liégeois et al.
BRAIN RESEARCH (2002)
Convergent evidence from microdialysis and presynaptic immunolabeling for the regulation of γ-aminobutyric acid release in the globus pallidus following acute clozapine or haloperidol administration in rats
RE See et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort
ML Buchholzer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat
S Shirazi-Southall et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Theory relating in vitro and in vivo microdialysis with one or two probes
KC Chen et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research
MV Solanto
BEHAVIOURAL BRAIN RESEARCH (2002)
MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats
N Jonkers et al.
BRAIN RESEARCH (2002)
Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum
J Ichikawa et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys
PW Czoty et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals
GJ Carey et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
The expression of vesicular glutamate transporters defines two classes of excitatory synapse
RT Fremeau et al.
NEURON (2001)
5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation:: a possible mechanism of atypical antipsychotic-induced cortical dopamine release
J Ichikawa et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Application of in vivo microdialysis to the study of cholinergic systems
JC Day et al.
METHODS (2001)
Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment
E Petroske et al.
NEUROSCIENCE (2001)
Glucose plus choline improve passive avoidance behaviour and increase hippocampal acetylcholine release in mice
SR Kopf et al.
NEUROSCIENCE (2001)
An evaluation of I-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate
JF Bowyer et al.
TOXICOLOGICAL SCIENCES (2000)
New selective and potent 5-HT1B/1D antagonists:: Chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides
Y Liao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
